These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
99 related items for PubMed ID: 1266099
1. [Treatment of obesity using a new anorectic]. Felt V. Vnitr Lek; 1976 Apr; 22(4):371-4. PubMed ID: 1266099 [No Abstract] [Full Text] [Related]
3. [Mazindol (AN-448): a new non-amphetamine anorectic in the treatment of exogenous obesity]. Delitala G, Alagna S, Masala A. Clin Ter; 1977 Jun 30; 81(6):547-54. PubMed ID: 884939 [No Abstract] [Full Text] [Related]
4. [Mazindol: a new anorectic drug]. Siani V. Clin Ter; 1978 Jan 15; 84(1):100-1. PubMed ID: 630811 [No Abstract] [Full Text] [Related]
5. AN 448 Sandoz (Mazindol) in the treatment of obesity. Wallace AG. Med J Aust; 1976 Mar 13; 1(11):343-5. PubMed ID: 775265 [Abstract] [Full Text] [Related]
6. [Clinical evaluation of Teronac (mazindol) in the treatment of obesity in children. Part II. Anorectic properties and side effects (author's transl)]. Gołebiowska M, Chlebna-Sokół D, Kobierska I, Konopińska A, Małek M, Mastalska A, Zwaigzne-Raczyńska J. Przegl Lek; 1981 Mar 13; 38(3):355-8. PubMed ID: 7017827 [No Abstract] [Full Text] [Related]
7. [Mazindol (Teronac) in the treatment of predominant by food-dependent obesity]. Husmann F. Med Welt; 1976 Oct 01; 27(40):1904-8. PubMed ID: 790077 [No Abstract] [Full Text] [Related]
8. Mazindol (Teronac)- another anorectic drug. Drug Ther Bull; 1974 Dec 20; 12(26):101-2. PubMed ID: 4459058 [No Abstract] [Full Text] [Related]
9. [Clinical use of mazindol in the treatment of essential obesity]. Guazzelli R, Piazzini M, Conti C, Papi L, Strazzulla G, Matassi L. Clin Ter; 1987 Mar 15; 120(5):385-91. PubMed ID: 2953538 [No Abstract] [Full Text] [Related]
10. [Teronac in the treatment of obesity]. Zahorska-Markiewicz B. Pol Tyg Lek; 1976 Jun 21; 31(25):1085-7. PubMed ID: 781638 [No Abstract] [Full Text] [Related]
11. [Comparison of the anorectic effect of mazindol and placebo in obesity]. Tatoń J, Czech A, Koliński P, Podwysocka G. Pol Tyg Lek; 1979 Dec 10; 34(50):1967-70. PubMed ID: 395517 [No Abstract] [Full Text] [Related]
12. [Treatment of obesity with a non-amphetamine anorexigenic agent (author's transl)]. Riesco J, Troncoso G, Costamaillere L, Rodríguez J. Rev Med Chil; 1977 Jun 10; 105(6):375-9. PubMed ID: 331428 [No Abstract] [Full Text] [Related]
13. [Mazindol (AN 448 Sandoz) in ambulatory treatment of obesity; its effect on body composition and adipose tissue]. Rath R, Vondra K, Wenkeová J. Cesk Gastroenterol Vyz; 1977 Sep 10; 31(6):389-94. PubMed ID: 589677 [No Abstract] [Full Text] [Related]
14. [Treatment of obesity with mazindol (author's transl)]. Escher M. Schweiz Rundsch Med Prax; 1976 Jun 15; 65(24):751-4. PubMed ID: 981189 [No Abstract] [Full Text] [Related]
15. [Clinical trial with a nonamphetaminic anoretic]. Campagnoli M. Rev Iber Endocrinol; 1976 Jun 15; 23(137):463-83. PubMed ID: 794978 [Abstract] [Full Text] [Related]
16. [Mazindol in the treatment of obese diabetic patients]. Dolecek R, Reil P, Skarpová O, Závada M. Vnitr Lek; 1976 Aug 15; 22(8):798-804. PubMed ID: 788327 [No Abstract] [Full Text] [Related]
17. A multi-centre general practice trial of mazindol in the treatment of obesity. Maclay WP, Wallace MG. Practitioner; 1977 Mar 15; 218(1305):431-4. PubMed ID: 322112 [No Abstract] [Full Text] [Related]
18. Mazindol. Med Lett Drugs Ther; 1982 Oct 29; 24(621):98. PubMed ID: 7144688 [No Abstract] [Full Text] [Related]
19. [Long-term treatment of patients with obesity using mazindol and a reducing diet]. van Seters AP, Bouwhuis-Hoogerwerf ML, Goslings BM, van Nieuwkoop L, van Slooten H, Struijk-Wielinga T. Ned Tijdschr Geneeskd; 1982 May 29; 126(22):990-4. PubMed ID: 7110390 [No Abstract] [Full Text] [Related]
20. Maziniol in the treatment of obesity. Sedgwick JP. Practitioner; 1975 Mar 29; 214(1281):418-20. PubMed ID: 1096123 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]